QURA THERAPEUTICS Trademark

Trademark Overview

On Wednesday, July 22, 2015, a trademark application was filed for QURA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the QURA THERAPEUTICS trademark a serial number of 86701353. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 9, 2024. This trademark is owned by Qura Therapeutics, LLC. The QURA THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of HIV and AIDS; scientific research for medical purposes
qura therapeutics

General Information

Serial Number86701353
Word MarkQURA THERAPEUTICS
Filing DateWednesday, July 22, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 9, 2024
Registration Number5187251
Registration DateTuesday, April 18, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2016

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch and development in the field of HIV and AIDS; scientific research for medical purposes

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 9, 2024
Primary Code042
First Use Anywhere DateWednesday, September 30, 2015
First Use In Commerce DateWednesday, September 30, 2015

Trademark Owner History

Party NameQura Therapeutics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressChapel Hill, NC 27599
Party NameQura Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressChapel Hill, NC 27599
Party NameQura Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressChapel Hill, NC 27599

Trademark Events

Event DateEvent Description
Saturday, February 10, 2024NOTICE OF CANCELLATION SEC. 8 EMAILED
Friday, February 9, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, August 8, 2023POST REGISTRATION ACTION MAILED - SEC. 8
Tuesday, August 8, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 3, 2023TEAS SECTION 8 RECEIVED
Wednesday, November 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 18, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 18, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, March 15, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 14, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 22, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, January 30, 2017USE AMENDMENT FILED
Wednesday, February 15, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 30, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, August 2, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 7, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 18, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 4, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 30, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 29, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 29, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 2, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 2, 2015NON-FINAL ACTION E-MAILED
Monday, November 2, 2015NON-FINAL ACTION WRITTEN
Monday, November 2, 2015ASSIGNED TO EXAMINER
Wednesday, July 29, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 25, 2015NEW APPLICATION ENTERED

Related Keywords

therapeutics qura research medical purposes scientific aids development field